Zeiser, R., Blazar, B.R., Acute graft-versus-host disease - biologic process, prevention, and therapy. N. Engl. J. Med. 377 (2017), 2167–2179, 10.1056/NEJMra1609337.
Socié, G., Ritz, J., Current issues in chronic graft-versus-host disease. Blood 124 (2014), 374–384, 10.1182/blood-2014-01-514752.
Weiden, P.L., Sullivan, K.M., Flournoy, N., Storb, R., Thomas, E.D., Seattle Marrow Transplant Team. Antileukemic effect of chronic graft-versus-host disease: contribution to improved survival after allogeneic marrow transplantation. N. Engl. J. Med. 304 (1981), 1529–1533, 10.1056/NEJM198106183042507.
Baron, F., Maris, M.B., Sandmaier, B.M., Storer, B.E., Sorror, M., Diaconescu, R., Woolfrey, A.E., Chauncey, T.R., Flowers, M.E.D., Mielcarek, M., et al. Graft-versus-tumor effects after allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning. J. Clin. Oncol. 23 (2005), 1993–2003, 10.1200/JCO.2005.08.136.
Baron, F., Labopin, M., Niederwieser, D., Vigouroux, S., Cornelissen, J.J., Malm, C., Vindelov, L.L., Blaise, D., Janssen, J.J.W.M., Petersen, E., et al. Impact of graft-versus-host disease after reduced-intensity conditioning allogeneic stem cell transplantation for acute myeloid leukemia: a report from the Acute Leukemia Working Party of the European group for blood and marrow transplantation. Leukemia 26 (2012), 2462–2468, 10.1038/leu.2012.135.
Storb, R., Antin, J.H., Cutler, C., Should methotrexate plus calcineurin inhibitors be considered standard of care for prophylaxis of acute graft-versus-host disease?. Biol. Blood Marrow Transplant. 16 (2010), S18–S27, 10.1016/j.bbmt.2009.10.016.
Baron, F., Mohty, M., Blaise, D., Socié, G., Labopin, M., Esteve, J., Ciceri, F., Giebel, S., Gorin, N.C., Savani, B.N., et al. Anti-thymocyte globulin as graft-versus-host disease prevention in the setting of allogeneic peripheral blood stem cell transplantation: a review from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation. Haematologica 102 (2017), 224–234, 10.3324/haematol.2016.148510.
Kanakry, C.G., Fuchs, E.J., Luznik, L., Modern approaches to HLA-haploidentical blood or marrow transplantation. Nat. Rev. Clin. Oncol., 13, 2016, 132, 10.1038/nrclinonc.2015.234.
Brissot, E., Labopin, M., Moiseev, I., Cornelissen, J.J., Meijer, E., Van Gorkom, G., Rovira, M., Ciceri, F., Griskevicius, L., Blaise, D., et al. Post-transplant cyclophosphamide versus antithymocyte globulin in patients with acute myeloid leukemia in first complete remission undergoing allogeneic stem cell transplantation from 10/10 HLA-matched unrelated donors. J. Hematol. Oncol., 13, 2020, 87, 10.1186/s13045-020-00923-0.
Dholaria, B., Labopin, M., Sanz, J., Ruggeri, A., Cornelissen, J., Labussière-Wallet, H., Blaise, D., Forcade, E., Chevallier, P., Grassi, A., et al. Allogeneic hematopoietic cell transplantation with cord blood versus mismatched unrelated donor with post-transplant cyclophosphamide in acute myeloid leukemia. J. Hematol. Oncol., 14, 2021, 76, 10.1186/s13045-021-01086-2.
Shaw, B.E., Jimenez-Jimenez, A.M., Burns, L.J., Logan, B.R., Khimani, F., Shaffer, B.C., Shah, N.N., Mussetter, A., Tang, X.-Y., McCarty, J.M., et al. National marrow donor program-sponsored multicenter, phase II trial of HLA-mismatched unrelated donor bone marrow transplantation using post-transplant cyclophosphamide. J. Clin. Oncol. 39 (2021), 1971–1982, 10.1200/JCO.20.03502.
Baron, F., Labopin, M., Tischer, J., Ciceri, F., Raiola, A.M., Blaise, D., Sica, S., Vydra, J., Fanin, R., Stölzel, F., et al. HLA-haploidentical transplantation for relapsed/refractory AML: better LFS with BM than with PBSC in patients ≥ 55 years of age. Am. J. Hematol. 97 (2022), 1065–1074, 10.1002/ajh.26627.
Ganguly, S., Ross, D.B., Panoskaltsis-Mortari, A., Kanakry, C.G., Blazar, B.R., Levy, R.B., Luznik, L., Donor CD4+ Foxp3+ regulatory T cells are necessary for posttransplantation cyclophosphamide-mediated protection against GVHD in mice. Blood 124 (2014), 2131–2141, 10.1182/blood-2013-10-525873.
Kanakry, C.G., Ganguly, S., Zahurak, M., Bolaños-Meade, J., Thoburn, C., Perkins, B., Fuchs, E.J., Jones, R.J., Hess, A.D., Luznik, L., Aldehyde dehydrogenase expression drives human regulatory T cell resistance to posttransplantation cyclophosphamide. Sci. Transl. Med., 5, 2013, 211ra157, 10.1126/scitranslmed.3006960.
Zhao, C., Bartock, M., Jia, B., Shah, N., Claxton, D.F., Wirk, B., Rakszawski, K.L., Nickolich, M.S., Naik, S.G., Rybka, W.B., et al. Post-transplant cyclophosphamide alters immune signatures and leads to impaired T cell reconstitution in allogeneic hematopoietic stem cell transplant. J. Hematol. Oncol., 15, 2022, 64, 10.1186/s13045-022-01287-3.
Massoud, R., Gagelmann, N., Fritzsche-Friedland, U., Zeck, G., Heidenreich, S., Wolschke, C., Ayuk, F., Christopeit, M., Kröger, N., Comparison of immune reconstitution between anti-T-lymphocyte globulin and post-transplant cyclophosphamide as acute graft-versus-host disease prophylaxis in allogeneic myeloablative peripheral blood stem cell transplantation. Haematologica 107 (2022), 857–867, 10.3324/haematol.2020.271445.
McCurdy, S.R., Radojcic, V., Tsai, H.-L., Vulic, A., Thompson, E., Ivcevic, S., Kanakry, C.G., Powell, J.D., Lohman, B., Adom, D., et al. Signatures of GVHD and relapse after post-transplant cyclophosphamide revealed by immune profiling and machine learning. Blood 139 (2022), 608–623, 10.1182/blood.2021013054.
King, M.A., Covassin, L., Brehm, M.A., Racki, W., Pearson, T., Leif, J., Laning, J., Fodor, W., Foreman, O., Burzenski, L., et al. Human peripheral blood leucocyte non-obese diabetic-severe combined immunodeficiency interleukin-2 receptor gamma chain gene mouse model of xenogeneic graft-versus-host-like disease and the role of host major histocompatibility complex. Clin. Exp. Immunol. 157 (2009), 104–118, 10.1111/j.1365-2249.2009.03933.x.
Kawasaki, Y., Sato, K., Hayakawa, H., Takayama, N., Nakano, H., Ito, R., Mashima, K., Oh, I., Minakata, D., Yamasaki, R., et al. Comprehensive analysis of the activation and proliferation kinetics and effector functions of human lymphocytes, and antigen presentation capacity of antigen-presenting cells in xenogeneic graft-versus-host disease. Biol. Blood Marrow Transplant. 24 (2018), 1563–1574, 10.1016/j.bbmt.2018.04.016.
Furlan, S.N., Watkins, B., Tkachev, V., Flynn, R., Cooley, S., Ramakrishnan, S., Singh, K., Giver, C., Hamby, K., Stempora, L., et al. Transcriptome analysis of GVHD reveals aurora kinase A as a targetable pathway for disease prevention. Sci. Transl. Med., 7, 2015, 315ra191, 10.1126/scitranslmed.aad3231.
Ehx, G., Somja, J., Warnatz, H.-J., Ritacco, C., Hannon, M., Delens, L., Fransolet, G., Delvenne, P., Muller, J., Beguin, Y., et al. Xenogeneic graft-versus-host disease in humanized NSG and NSG-HLA-A2/HHD mice. Front. Immunol., 9, 2018, 1943, 10.3389/fimmu.2018.01943.
Ehx, G., Ritacco, C., Hannon, M., Dubois, S., Delens, L., Willems, E., Servais, S., Drion, P., Beguin, Y., Baron, F., Comprehensive analysis of the immunomodulatory effects of rapamycin on human T cells in graft-versus-host disease prophylaxis. Am. J. Transplant. 21 (2021), 2662–2674, 10.1111/ajt.16505.
Ali, N., Flutter, B., Sanchez Rodriguez, R., Sharif-Paghaleh, E., Barber, L.D., Lombardi, G., Nestle, F.O., Xenogeneic graft-versus-host-disease in NOD-scid IL-2Rγnull mice display a T-effector memory phenotype. PLoS One, 7, 2012, e44219, 10.1371/journal.pone.0044219.
Johnson, S.A., Seale, S.L., Gittelman, R.M., Rytlewski, J.A., Robins, H.S., Fields, P.A., Impact of HLA type, age and chronic viral infection on peripheral T-cell receptor sharing between unrelated individuals. PLoS One, 16, 2021, e0249484, 10.1371/journal.pone.0249484.
Soto, C., Bombardi, R.G., Kozhevnikov, M., Sinkovits, R.S., Chen, E.C., Branchizio, A., Kose, N., Day, S.B., Pilkinton, M., Gujral, M., et al. High frequency of shared clonotypes in human T cell receptor repertoires. Cell Rep., 32, 2020, 107882, 10.1016/j.celrep.2020.107882.
Trofimov, A., Brouillard, P., Larouche, J.-D., Séguin, J., Laverdure, J.-P., Brasey, A., Ehx, G., Roy, D.-C., Busque, L., Lachance, S., et al. Two types of human TCR differentially regulate reactivity to self and non-self antigens. iScience, 25, 2022, 104968, 10.1016/j.isci.2022.104968.
Pierson, W., Cauwe, B., Policheni, A., Schlenner, S.M., Franckaert, D., Berges, J., Humblet-Baron, S., Schönefeldt, S., Herold, M.J., Hildeman, D., et al. Antiapoptotic Mcl-1 is critical for the survival and niche-filling capacity of Foxp3(+) regulatory T cells. Nat. Immunol. 14 (2013), 959–965, 10.1038/ni.2649.
Liston, A., Gray, D.H.D., Homeostatic control of regulatory T cell diversity. Nat. Rev. Immunol. 14 (2014), 154–165, 10.1038/nri3605.
Pérol, L., Martin, G.H., Maury, S., Cohen, J.L., Piaggio, E., Potential limitations of IL-2 administration for the treatment of experimental acute graft-versus-host disease. Immunol. Lett. 162 (2014), 173–184, 10.1016/j.imlet.2014.10.027.
Mutis, T., van Rijn, R.S., Simonetti, E.R., Aarts-Riemens, T., Emmelot, M.E., van Bloois, L., Martens, A., Verdonck, L.F., Ebeling, S.B., Human regulatory T cells control xenogeneic graft-versus-host disease induced by autologous T cells in RAG2-/-gammac-/- immunodeficient mice. Clin. Cancer Res. 12 (2006), 5520–5525, 10.1158/1078-0432.CCR-06-0035.
Hippen, K.L., Merkel, S.C., Schirm, D.K., Sieben, C.M., Sumstad, D., Kadidlo, D.M., McKenna, D.H., Bromberg, J.S., Levine, B.L., Riley, J.L., et al. Massive ex vivo expansion of human natural regulatory T cells (T(regs)) with minimal loss of in vivo functional activity. Sci. Transl. Med., 3, 2011, 83ra41, 10.1126/scitranslmed.3001809.
Aryee, K.-E., Burzenski, L.M., Yao, L.-C., Keck, J.G., Greiner, D.L., Shultz, L.D., Brehm, M.A., Enhanced development of functional human NK cells in NOD-scid-IL2rg(null) mice expressing human IL15. Faseb. J., 36, 2022, e22476, 10.1096/fj.202200045R.
Ehx, G., Fransolet, G., de Leval, L., D'Hondt, S., Lucas, S., Hannon, M., Delens, L., Dubois, S., Drion, P., Beguin, Y., et al. Azacytidine prevents experimental xenogeneic graft-versus-host disease without abrogating graft-versus-leukemia effects. OncoImmunology, 6, 2017, e1314425, 10.1080/2162402X.2017.1314425.
Adhikary, S.R., Cuthbertson, P., Nicholson, L., Bird, K.M., Sligar, C., Hu, M., O'Connell, P.J., Sluyter, R., Alexander, S.I., Watson, D., Post-transplant cyclophosphamide limits reactive donor T cells and delays the development of graft-versus-host disease in a humanized mouse model. Immunology 164 (2021), 332–347, 10.1111/imm.13374.
Covington, M., He, X., Scuron, M., Li, J., Collins, R., Juvekar, A., Shin, N., Favata, M., Gallagher, K., Sarah, S., et al. Preclinical characterization of itacitinib (INCB039110), a novel selective inhibitor of JAK1, for the treatment of inflammatory diseases. Eur. J. Pharmacol., 885, 2020, 173505, 10.1016/j.ejphar.2020.173505.
Ziegler, S.F., FOXP3: of mice and men. Annu. Rev. Immunol. 24 (2006), 209–226, 10.1146/annurev.immunol.24.021605.090547.
Matsuoka, K.i., Koreth, J., Kim, H.T., Bascug, G., McDonough, S., Kawano, Y., Murase, K., Cutler, C., Ho, V.T., Alyea, E.P., et al. Low-dose interleukin-2 therapy restores regulatory T cell homeostasis in patients with chronic graft-versus-host disease. Sci. Transl. Med., 5, 2013, 179ra43, 10.1126/scitranslmed.3005265.
Ritacco, C., Ehx, G., Grégoire, C., Daulne, C., Willems, E., Servais, S., Beguin, Y., Baron, F., High proportion of terminally differentiated regulatory T cells after allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant. 56 (2021), 1828–1841, 10.1038/s41409-021-01221-0.
Humblet-Baron, S., Franckaert, D., Dooley, J., Bornschein, S., Cauwe, B., Schönefeldt, S., Bossuyt, X., Matthys, P., Baron, F., Wouters, C., Liston, A., IL-2 consumption by highly activated CD8 T cells induces regulatory T-cell dysfunction in patients with hemophagocytic lymphohistiocytosis. J. Allergy Clin. Immunol. 138 (2016), 200–209.e8, 10.1016/j.jaci.2015.12.1314.
Abraham, S., Pahwa, R., Ye, C., Choi, J.-G., Pahwa, S., Jaggaiahgari, S., Raut, A., Chen, S., Manjunath, N., Shankar, P., Long-term engraftment of human natural T regulatory cells in NOD/SCID IL2rγc(null) mice by expression of human IL-2. PLoS One, 7, 2012, e51832, 10.1371/journal.pone.0051832.
Betts, B.C., Veerapathran, A., Pidala, J., Yang, H., Horna, P., Walton, K., Cubitt, C.L., Gunawan, S., Lawrence, H.R., Lawrence, N.J., et al. Targeting Aurora kinase A and JAK2 prevents GVHD while maintaining Treg and antitumor CTL function. Sci. Transl. Med., 9, 2017, eaai8269, 10.1126/scitranslmed.aai8269.
Pogorelyy, M.V., Minervina, A.A., Touzel, M.P., Sycheva, A.L., Komech, E.A., Kovalenko, E.I., Karganova, G.G., Egorov, E.S., Komkov, A.Y., Chudakov, D.M., et al. Precise tracking of vaccine-responding T cell clones reveals convergent and personalized response in identical twins. Proc. Natl. Acad. Sci. USA 115 (2018), 12704–12709, 10.1073/pnas.1809642115.
Yu, X.G., Lichterfeld, M., Williams, K.L., Martinez-Picado, J., Walker, B.D., Random T-cell receptor recruitment in human immunodeficiency virus type 1 (HIV-1)-specific CD8+ T cells from genetically identical twins infected with the same HIV-1 strain. J. Virol. 81 (2007), 12666–12669, 10.1128/JVI.01450-07.
Kanakry, C.G., Coffey, D.G., Towlerton, A.M.H., Vulic, A., Storer, B.E., Chou, J., Yeung, C.C.S., Gocke, C.D., Robins, H.S., O'Donnell, P.V., et al. Origin and evolution of the T cell repertoire after posttransplantation cyclophosphamide. JCI Insight, 1, 2016, e86252, 10.1172/jci.insight.86252.
Shimoni, A., Labopin, M., Angelucci, E., Blaise, D., Ciceri, F., Koc, Y., Gülbas, Z., Diez-Martin, J.L., Bruno, B., Castagna, L., et al. The association of graft-versus-leukemia effect and graft-versus host disease in haploidentical transplantation with post-transplant cyclophosphamide for AML. Bone Marrow Transplant. 57 (2022), 384–390, 10.1038/s41409-021-01493-6.
Cany, J., van der Waart, A.B., Spanholtz, J., Tordoir, M., Jansen, J.H., van der Voort, R., Schaap, N.M., Dolstra, H., Combined IL-15 and IL-12 drives the generation of CD34(+)-derived natural killer cells with superior maturation and alloreactivity potential following adoptive transfer. OncoImmunology, 4, 2015, e1017701, 10.1080/2162402X.2015.1017701.
Pyo, K.H., Kim, J.H., Lee, J.-M., Kim, S.E., Cho, J.S., Lim, S.M., Cho, B.C., Promising preclinical platform for evaluation of immuno-oncology drugs using Hu-PBL-NSG lung cancer models. Lung Cancer 127 (2019), 112–121, 10.1016/j.lungcan.2018.11.035.
Hannon, M., Lechanteur, C., Lucas, S., Somja, J., Seidel, L., Belle, L., Bruck, F., Baudoux, E., Giet, O., Chantillon, A.-M., et al. Infusion of clinical-grade enriched regulatory T cells delays experimental xenogeneic graft-versus-host disease. Transfusion 54 (2014), 353–363, 10.1111/trf.12279.
SIMPSON, E.H., Measurement of diversity. Nature, 163, 1949, 688, 10.1038/163688a0.
DeWitt, W.S., Emerson, R.O., Lindau, P., Vignali, M., Snyder, T.M., Desmarais, C., Sanders, C., Utsugi, H., Warren, E.H., McElrath, J., et al. Dynamics of the cytotoxic T cell response to a model of acute viral infection. J. Virol. 89 (2015), 4517–4526, 10.1128/JVI.03474-14.
Benjamini, Y., Hochberg, Y., Controlling the False Discovery rate: a practical and powerful approach to multiple testing. J. Roy. Stat. Soc. B 57 (1995), 289–300, 10.1111/j.2517-6161.1995.tb02031.x.
Zheng, G.X.Y., Terry, J.M., Belgrader, P., Ryvkin, P., Bent, Z.W., Wilson, R., Ziraldo, S.B., Wheeler, T.D., McDermott, G.P., Zhu, J., et al. Massively parallel digital transcriptional profiling of single cells. Nat. Commun., 8, 2017, 14049, 10.1038/ncomms14049.
Satija, R., Farrell, J.A., Gennert, D., Schier, A.F., Regev, A., Spatial reconstruction of single-cell gene expression data. Nat. Biotechnol. 33 (2015), 495–502, 10.1038/nbt.3192.
Korsunsky, I., Millard, N., Fan, J., Slowikowski, K., Zhang, F., Wei, K., Baglaenko, Y., Brenner, M., Loh, P.-R., Raychaudhuri, S., Fast, sensitive and accurate integration of single-cell data with Harmony. Nat. Methods 16 (2019), 1289–1296, 10.1038/s41592-019-0619-0.
Becht, E., McInnes, L., Healy, J., Dutertre, C.-A., Kwok, I.W.H., Ng, L.G., Ginhoux, F., Newell, E.W., Dimensionality reduction for visualizing single-cell data using UMAP. Nat. Biotechnol. 37 (2018), 38–44, 10.1038/nbt.4314.
Traag, V.A., Waltman, L., van Eck, N.J., From Louvain to Leiden: guaranteeing well-connected communities. Sci. Rep., 9, 2019, 5233, 10.1038/s41598-019-41695-z.
Tirosh, I., Izar, B., Prakadan, S.M., Wadsworth, M.H. 2nd, Treacy, D., Trombetta, J.J., Rotem, A., Rodman, C., Lian, C., Murphy, G., et al. Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq. Science 352 (2016), 189–196, 10.1126/science.aad0501.
Subramanian, A., Tamayo, P., Mootha, V.K., Mukherjee, S., Ebert, B.L., Gillette, M.A., Paulovich, A., Pomeroy, S.L., Golub, T.R., Lander, E.S., Mesirov, J.P., Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. USA 102 (2005), 15545–15550, 10.1073/pnas.0506580102.
